by the Macular Degeneration Foundation
Rob Nevin – BlindSquare GPS IOS App for blind and low vision navigation
Pravin U Dugel, MD Retinal Associates of Arizona — HAWK & HARRIER: 48–week Results Of 2 Multi-Centered, Randomized, Double-Masked Trials of Brolucizumab Versus Aflibercept For Neovascular AMD and promising future treatments
John Shepherd, MD The Weigel Williamson Center for Visual Rehabilitation University Nebraska Medical Center — Why should I Consult a Low Vision Specialist?
David Boyer, MD Retina-Vitreous Specialists Medical Group — Emerging Dry Macular Degeneration Treatments
Dr. Ron Gentile, MD, FACS, FASRS New York Eye and Ear of Mount Sinai Patient Satisfaction and expectations
Dr. Joe Fontenot, MD, CLVT Community Service for Vision Rehabilitation http://www.csvrlowvision.org Low vision technology
University Sydney Australia Macular Research Group, Save Sight Institute Treatment Patterns and visual outcomes for AMD
University of Poitiers – Poitiers, France Using IPS Cells to Develop Molecular Therapy for AMD
University of Michigan Kellogg Eye Center Automated Quantification of Subcellular Structures in the RPE: Lipid Droplets, Autophagic Vacuoles, and Lipofuscin
Induced stem cells, RPE cells and translational applications for degenerative eye diseases.
Research into mitochondria function and protein degradation in macular degeneration.
Looking at molecular reason for non-response in Anti-VEGF treatment
Identifying pathways that induce vision loss as a consequence of drusen in Age Related Macular Degeneration
Explaining Clinical Trials, Requirements, procedure and efficacy for participation.
Understanding underlying mechanisms of degenerative diseases
Jack Sullivan, MD, PhD Development of gene-based therapeutics for retinal and macular degeneration
Ed Boyden, PhD Optogenetics – a method for manipulating the activity of nerve cells using light and cell mapping
Moran Eye Center University of Utah School of Medicine Genome-Wide Analysis of Allele Specific Expression Demonstrates the Role of Lipid Metabolism in AMD
Perelman Medical School University of Pennsylvania Roles of iron overload and oxidative stress in the blinding disease age-related macular degeneration
Schepens Eye Research Institute Massachusetts Eye and Ear The effects of Lipids and Inflamasones on AMD
Fordham University The RPE Cytoskeleton: Regulating RPE Function and Potency, and Changes with Age-related Oxidative Stress
Harvard University: Department of Molecular and Cellular Biology The Human Fovea and Age-Related Macular Degeneration
Department of Ophthalmology, University of Basel & Wilmer Eye Institute at Johns Hopkins University Genetic Testing and Gene Therapy for Stargardt Disease & Macular Degeneration
Philip Hessburg, MD Detroit Institute of Ophthalmology Eye and the Chip
Retina Consultants of Houston Houston Methodist Blanton Eye Institute TREX: Monthly vs. Treat and Extend for Neovascular AMD
Select any channel below to view all posts within that channel:
Enter your email address to follow Macular News and receive notifications when new videos and/or newsletters are first posted
Blog at WordPress.com.